Synthetic protein tweak could lead to universal cancer immunotherapy
Scientists at ETH Zurich have made a breakthrough towards designing an off-the-shelf treatment for immunotherapy against cancer. A synthetic protein tweak can allow immune cells from any donor to be given to any patient without the risk of a dangerous … Continue reading Synthetic protein tweak could lead to universal cancer immunotherapy
